Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

NCT05425719 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: MB-102
DEVICE: MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)

Sponsor

MediBeacon